Epidemiology of Parkinson’s disease

Epidemiological research aims to provide information on the development, prevalence and progression of diseases, and their associated risk factors. Epidemiological research is thus the basis of increasing our understanding on the aetiology of diseases and as a consequence the starting point for identifying at risk groups in the population, development for novel prevention and treatment strategies, and health care planning. This review provides an overview of the epidemiology of Parkinson’s disease, the second most common neurodegenerative disorder, with special emphasis on population-based data on the clinical progression of motor and non-motor features of the disease.

[1]  K. Marder,et al.  The association of incident dementia with mortality in PD , 2002, Neurology.

[2]  Yaakov Stern,et al.  Combined effect of age and severity on the risk of dementia in Parkinson's disease , 2002, Annals of neurology.

[3]  A. Stiggelbout,et al.  Systematic evaluation of rating scales for impairment and disability in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[4]  P. Morrish.  How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease? , 2003, Movement disorders : official journal of the Movement Disorder Society.

[5]  Leonard Petrucelli,et al.  Molecular pathogenesis of Parkinson disease. , 2005, Archives of neurology.

[6]  J. Jankovic,et al.  Exploring the relationship between Parkinson disease and restless legs syndrome. , 2002, Archives of neurology.

[7]  P. Bruin,et al.  Snoring and excessive daytime sleepiness in Parkinson's disease , 2004, Journal of the Neurological Sciences.

[8]  D. Aarsland,et al.  Changes in motor subtype and risk for incident dementia in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[9]  P. Moberg,et al.  Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. , 1998, Archives of neurology.

[10]  V. Laulumaa,et al.  Economic burden and quality of life impairment increase with severity of PD. , 2003, Parkinsonism & related disorders.

[11]  D. Burn,et al.  Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[13]  F. Verhey,et al.  Higher incidence of depression preceding the onset of Parkinson's disease: A register study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[14]  D. Aarsland,et al.  Familial Parkinson's disease: a community‐based study , 2003, European journal of neurology.

[15]  T. Jhou,et al.  Identification of Wake-Active Dopaminergic Neurons in the Ventral Periaqueductal Gray Matter , 2006, The Journal of Neuroscience.

[16]  T. Miyaoka,et al.  Prevalence of restless legs syndrome in non‐institutionalized Japanese elderly , 2005, Psychiatry and clinical neurosciences.

[17]  P. Hobson,et al.  Accuracy of Diagnosis in Patients with Presumed Parkinson's Disease in a Community Based Disease Register , 1997 .

[18]  D. Schaid,et al.  Anxiety disorders and depressive disorders preceding Parkinson's disease: A case‐control study , 2000, Movement disorders : official journal of the Movement Disorder Society.

[19]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[20]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[21]  A. Bentivoglio,et al.  Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. , 2001, American journal of human genetics.

[22]  J. Friedman,et al.  Effects of fatigue on physical activity and function in patients with Parkinson’s disease , 2003, Neurology.

[23]  E. Lainey,et al.  Epidemiology of restless legs syndrome in French adults , 2005, Neurology.

[24]  E. Meseguer,et al.  Motor Complications in Parkinson Disease:: A Prospective Follow-Up Study , 2004, Clinical neuropharmacology.

[25]  D. Aarsland,et al.  Excessive daytime sleepiness in Parkinson disease , 2006, Neurology.

[26]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.

[27]  A. Hout,et al.  Dementia and survival in Parkinson disease , 2008, Neurology.

[28]  Yoav Ben-Shlomo,et al.  How common are complications of Parkinson's disease? , 2002, Journal of Neurology.

[29]  B. Müller-Myhsok,et al.  A susceptibility locus for Parkinson's disease maps to chromosome 2p13 , 1998, Nature Genetics.

[30]  T. Bolwig,et al.  Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study , 2001, Acta psychiatrica Scandinavica.

[31]  Kiyoharu Inoue,et al.  Cardiovascular dysautonomia in de novo Parkinson's disease , 2006, Journal of the Neurological Sciences.

[32]  C. Goetz,et al.  Hallucinations in Parkinson disease in the prelevodopa era , 2006, Neurology.

[33]  G. Naglie,et al.  Survival in Parkinson disease , 2005, Neurology.

[34]  W. Weiner,et al.  Comorbidity of the nonmotor symptoms of Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[35]  J. Cummings,et al.  The occurrence of depression in Parkinson's disease. A community-based study. , 1996, Archives of neurology.

[36]  C. Olanow,et al.  The pathogenesis of cell death in Parkinson's disease , 2006, Neurology.

[37]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[38]  W. Weiner,et al.  Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) , 2006, Neurology.

[39]  K. Marder,et al.  The frequency and associated risk factors for dementia in patients with Parkinson's disease. , 1995, Archives of neurology.

[40]  H. Ross,et al.  A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease , 2000, Neurology.

[41]  D. Aarsland,et al.  Development of daytime somnolence over time in Parkinson’s disease , 2002, Neurology.

[42]  K. Gwinn‐Hardy,et al.  Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group , 2007, Movement disorders : official journal of the Movement Disorder Society.

[43]  Mrc Psych,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .

[44]  D. Rye,et al.  FAST TRACK: daytime sleepiness in Parkinson's disease. , 2000, Journal of sleep research.

[45]  S. Lie,et al.  Mortality and Parkinson disease , 2004, Neurology.

[46]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[47]  J. A. Cook,et al.  Heterogeneity in male to female risk for Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[48]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[49]  K. Majamaa,et al.  Familial aggregation of Parkinson's disease in a Finnish population , 2000, Journal of neurology, neurosurgery, and psychiatry.

[50]  J. Langston,et al.  The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. , 1989, Science.

[51]  Ulf Persson,et al.  Resource use and costs in a Swedish cohort of patients with Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[52]  Daniel J Schaid,et al.  Survival study of Parkinson disease in Olmsted County, Minnesota. , 2003, Archives of neurology.

[53]  D. Aarsland,et al.  Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study , 2000, Journal of the American Geriatrics Society.

[54]  K. Marder,et al.  Motor impairment in PD , 2000, Neurology.

[55]  R. Bhidayasiri,et al.  Motor complications in Parkinson disease: Clinical manifestations and management , 2008, Journal of the Neurological Sciences.

[56]  T. Robbins,et al.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.

[57]  C. Adler,et al.  Sleep issues in Parkinson’s disease , 2005, Neurology.

[58]  E. Tan,et al.  Restless legs syndrome in an Asian population: A study in Singapore , 2001, Movement disorders : official journal of the Movement Disorder Society.

[59]  Nir Giladi,et al.  The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. , 2007, Parkinsonism & related disorders.

[60]  R. Uitti,et al.  Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. , 2005, Parkinsonism & related disorders.

[61]  Kenneth Hugdahl,et al.  Neuropsychological Profile of Patients with Parkinson’s Disease without Dementia , 2003, Dementia and Geriatric Cognitive Disorders.

[62]  P. Hobson,et al.  Accuracy of diagnosis in patients with presumed Parkinson's disease. , 1999, Age and ageing.

[63]  M. Beyer,et al.  Causes of death in a community‐based study of Parkinson's disease , 2001, Acta neurologica Scandinavica.

[64]  A. Lees,et al.  The clinical features of Parkinson's disease in 100 histologically proven cases. , 1993, Advances in neurology.

[65]  J. Godwin,et al.  Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. , 2005, International journal of epidemiology.

[66]  I. Litvan.  Parkinsonian features: when are they Parkinson disease? , 1998, JAMA.

[67]  Richard P Allen,et al.  Restless legs syndrome prevalence and impact: REST general population study. , 2005, Archives of internal medicine.

[68]  D J Brooks,et al.  An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. , 1996, Brain : a journal of neurology.

[69]  D. Woitalla,et al.  3-OMD and homocysteine plasma levels in parkinsonian patients , 2002, Journal of Neural Transmission.

[70]  A. Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.

[71]  G. Fénelon.  Psychosis in Parkinson's Disease: Phenomenology, Frequency, Risk Factors, and Current Understanding of Pathophysiologic Mechanisms , 2008, CNS Spectrums.

[72]  T. Roth,et al.  Waking up to sleep episodes in Parkinson's Disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[73]  T. Robbins,et al.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. , 2004, Brain : a journal of neurology.

[74]  R. Marin,et al.  Apathy: a neuropsychiatric syndrome. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[75]  D. Aarsland,et al.  Profile of cognitive impairment in dementia associated with Parkinson’s disease compared with Alzheimer’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[76]  G. E. Smith,et al.  Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism , 2003, Neurology.

[77]  J. Carrier,et al.  REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease , 2002, Neurology.

[78]  M. Mcdermott,et al.  Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease. , 2006, Archives of neurology.

[79]  S Fahn,et al.  Freezing of gait in PD , 2001, Neurology.

[80]  H. Braak,et al.  Cognitive status correlates with neuropathologic stage in Parkinson disease , 2005, Neurology.

[81]  Tore Wentzel-Larsen,et al.  The rate of cognitive decline in Parkinson disease. , 2004, Archives of neurology.

[82]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[83]  P. Rochon,et al.  Predicting motor decline and disability in Parkinson disease: a systematic review. , 2002, Archives of neurology.

[84]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[85]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: A follow‐up study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[86]  J. Cummings,et al.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. , 1999, Archives of neurology.

[87]  Mathias Toft,et al.  Clinical features of LRRK2‐associated Parkinson's disease in central Norway , 2005, Annals of neurology.

[88]  J. Cummings,et al.  Risk factors for depression in Parkinson disease. , 1997, Archives of neurology.

[89]  K. Marder,et al.  The effect of age of onset of PD on risk of dementia , 2007, Journal of Neurology.

[90]  U. Keil,et al.  Prevalence and risk factors of RLS in an elderly population , 2000, Neurology.

[91]  D. Aarsland,et al.  Progression of motor impairment and disability in Parkinson disease , 2005, Neurology.

[92]  P. Lespérance,et al.  Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria , 1997, Movement disorders : official journal of the Movement Disorder Society.

[93]  D. Aarsland,et al.  Insomnia in Parkinson’s disease: frequency and progression over time , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[94]  Lorene M Nelson,et al.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. , 2003, American journal of epidemiology.

[95]  I Litvan,et al.  Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study , 2000, Neurology.

[96]  Yaakov Stern,et al.  Dementia in Parkinson's disease , 1994, Neurology.

[97]  C. Tanner,et al.  Epidemiology of Parkinson's disease and akinetic syndromes , 2000, Current opinion in neurology.

[98]  Karl Herholz,et al.  Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. , 2005, Archives of neurology.

[99]  E. Tolosa,et al.  Immediate-release and controlled-release carbidopa/levodopa in PD , 1999, Neurology.

[100]  H. Berendse,et al.  Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.

[101]  Thomas Hummel,et al.  Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT , 2004, Movement disorders : official journal of the Movement Disorder Society.

[102]  M. Polymeropoulos,et al.  Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson’s disease , 1998, Human Genetics.

[103]  M. Adena,et al.  Age at onset: the major determinant of outcome in Parkinson's disease , 1995, Acta neurologica Scandinavica.

[104]  M. Behari,et al.  Restless legs syndrome in Parkinson's disease: A case‐controlled study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[105]  K. Anderson.  Dementia in Parkinsons disease , 2004 .

[106]  N. Wood,et al.  Molecular pathogenesis of Parkinson's disease. , 2005, Human molecular genetics.

[107]  Thomas Hummel,et al.  Olfactory loss may be a first sign of idiopathic Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[108]  S. Leurgans,et al.  Prospective longitudinal assessment of hallucinations in Parkinson’s disease , 2001, Neurology.

[109]  E. Tolosa,et al.  The premotor phase of Parkinson's disease. , 2007, Parkinsonism & related disorders.

[110]  C. Tanner,et al.  Association of olfactory dysfunction with risk for future Parkinson's disease , 2008, Annals of neurology.

[111]  M. Muenter,et al.  Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature , 2001, Movement disorders : official journal of the Movement Disorder Society.

[112]  I. McKeith,et al.  Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[113]  D J Foley,et al.  Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.

[114]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[115]  S. Fahn.  Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.

[116]  D. Rye,et al.  Daytime sleepiness in Parkinson’s disease , 2000 .

[117]  A. Lees.  Cognitive Deficits in Parkinson’s Disease , 1985 .

[118]  Jeremy Holmes,et al.  Direct economic impact of Parkinson's disease: A research survey in the United Kingdom , 2003, Movement disorders : official journal of the Movement Disorder Society.

[119]  K. Bötzel,et al.  Prevalence and incidence of Parkinson's disease in Europe , 2005, European Neuropsychopharmacology.

[120]  M. Allam,et al.  Parkinson's disease risk factors: genetic, environmental, or both? , 2005, Neurological research.

[121]  M. Brin,et al.  Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.

[122]  E. Tan,et al.  Case–control study of restless legs syndrome and quality of sleep in Parkinson's disease , 2008, Journal of the Neurological Sciences.

[123]  S. Dick.  Occupational and environmental risk factors for Parkinson's disease , 2005 .

[124]  M. Ceccaldi,et al.  Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling , 2002, Neurology.

[125]  Bart Post,et al.  UvA-DARE ( Digital Academic Repository ) Clinimetrics , clinical profile and prognosis in early Parkinson ’ s disease , 2009 .

[126]  A. Elbaz,et al.  Epidemiologic studies of environmental exposures in Parkinson's disease , 2007, Journal of the Neurological Sciences.

[127]  C. Saper,et al.  Hypothalamic regulation of sleep and circadian rhythms , 2005, Nature.

[128]  B. Boeve,et al.  Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy , 2001, Movement disorders : official journal of the Movement Disorder Society.

[129]  J. Larsen,et al.  Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[130]  Uwe Siebert,et al.  Rate of clinical progression in Parkinson's disease. A prospective study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[131]  Klaus Seppi,et al.  An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism , 2005, Current opinion in neurology.

[132]  A. Lees,et al.  A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.

[133]  F. Lalonde,et al.  Are Patients with Parkinson's Disease Suicidal? , 2001, Journal of geriatric psychiatry and neurology.

[134]  S. Lie,et al.  Cigarette smoking in Parkinson's disease: Influence on disease progression , 2004, Movement disorders : official journal of the Movement Disorder Society.

[135]  A. Lees,et al.  Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[136]  K. Kessler,et al.  Determinants of autonomic dysfunction in idiopathic Parkinson’s disease , 2005, Journal of Neurology.

[137]  A. Chaudhuri,et al.  Fatigue in neurological disorders , 2004, The Lancet.

[138]  Günther Deuschl,et al.  Falls in frequent neurological diseases--prevalence, risk factors and aetiology. , 2004, Journal of neurology.

[139]  J. Nutt,et al.  Exacerbated physical fatigue and mental fatigue in Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[140]  K. Marder,et al.  Progression of parkinsonian signs in Parkinson disease. , 1999, Archives of neurology.

[141]  D. Aarsland,et al.  Risk of dementia in Parkinson’s disease , 2001, Neurology.

[142]  C. Pollak,et al.  Periodic movements in sleep (nocturnal myoclonus): Relation to sleep disorders , 1980, Annals of neurology.

[143]  C. Olanow,et al.  The pathogenesis of cell death in Parkinson's disease – 2007 , 2007, Movement disorders : official journal of the Movement Disorder Society.

[144]  M. Hely,et al.  Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years , 2005, Movement disorders : official journal of the Movement Disorder Society.

[145]  A M Stiggelbout,et al.  Patient-reported autonomic symptoms in Parkinson disease , 2007, Neurology.

[146]  D. Aarsland,et al.  A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[147]  I. Appollonio,et al.  Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[148]  A. Lees,et al.  Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[149]  W. Poewe,et al.  Reply: Role of DAT SPECT in the diagnostic work‐up of Parkinsonism , 2008, Movement disorders : official journal of the Movement Disorder Society.

[150]  P. Andersen,et al.  Major depressive disorder in Parkinson's disease: a register‐based study , 2002, Acta psychiatrica Scandinavica.

[151]  D. Garcia-Borreguero,et al.  Parkinson's disease and sleep. , 2003, Sleep medicine reviews.

[152]  H. Reichmann,et al.  Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients , 2002, Journal of Neural Transmission.

[153]  M. Farrer,et al.  Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseSYMBOL , 2008, Neurology.

[154]  B. Djahanguiri,et al.  The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.

[155]  Ann Ashburn,et al.  A meta‐analysis of six prospective studies of falling in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[156]  J. Larsen,et al.  The influence of fatigue on health‐related quality of life in patients with Parkinson's disease , 2003, Acta neurologica Scandinavica.

[157]  R. Doty,et al.  Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[158]  Jane S. Paulsen,et al.  Apathy is not depression. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[159]  R. Brown,et al.  Apathy in Parkinson’s disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[160]  J. Boldsen,et al.  Suicide in patients with Parkinson's disease , 1994, Acta psychiatrica Scandinavica.

[161]  K A Jellinger.  How valid is the clinical diagnosis of Parkinson’s disease in the community? , 2003, Journal of neurology, neurosurgery, and psychiatry.

[162]  K. Nakashima,et al.  Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[163]  W. Poewe,et al.  The natural history of Parkinson's disease , 1996, Neurology.

[164]  V. Preedy,et al.  Unified Parkinson's Disease Rating Scale , 2010 .

[165]  U. Keil,et al.  Prevalence and risk factors of RLS in an elderly population , 2000, Neurology.

[166]  V. Patel,et al.  Chronic fatigue in developing countries: population based survey of women in India , 2005, BMJ : British Medical Journal.

[167]  D. Twelves,et al.  Systematic review of incidence studies of Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[168]  J. Houwing-Duistermaat,et al.  Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. , 2001, American journal of human genetics.

[169]  K. Planansky.  Paralysis agitans: A clinical and genetic study , 1950 .

[170]  B. Boeve,et al.  Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[171]  G. Wooten,et al.  Prospective study of hallucinations and delusions in Parkinson's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[172]  T Wentzel-Larsen,et al.  Is fatigue an independent and persistent symptom in patients with Parkinson disease? , 2004, Neurology.

[173]  J. Cummings,et al.  Range of neuropsychiatric disturbances in patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[174]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[175]  J. Larsen,et al.  Clinical problems in non‐fluctuating patients with Parkinson's disease: A community‐based study , 2000, Movement disorders : official journal of the Movement Disorder Society.

[176]  E. Tan.  Restless Legs Syndrome and Parkinson’s Disease: Is there an etiologic link? , 2006, Journal of Neurology.

[177]  Bastiaan R Bloem,et al.  Gender differences in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[178]  J. Larsen,et al.  A community‐based study of sleep disorders in patients with Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[179]  U. Bonuccelli,et al.  Orthostatic hypotension in de novo Parkinson disease. , 2003, Archives of neurology.

[180]  A. M. Smith,et al.  Abnormal co-contraction in yips-affected but not unaffected golfers: Evidence for focal dystonia , 2005, Neurology.

[181]  C. Tanner,et al.  Risk factors for progression in Parkinson's disease , 1988, Neurology.

[182]  C. Ward.  What contributes to quality of life in patients with Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[183]  Bastiaan R Bloem,et al.  Falls in Parkinson's disease , 2004, Current opinion in neurology.

[184]  P. Ince,et al.  Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease , 1991, Annals of the New York Academy of Sciences.

[185]  D. Aarsland,et al.  A systematic review of prevalence studies of depression in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[186]  Glenn T. Stebbins,et al.  Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease , 1998, Neurology.

[187]  Andrew J. Lees,et al.  Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.